Skip to content

Establishment and clinical study for the early warning model of spontaneous abortion based on combination of serum miRNAs

Establishment and clinical study for the early warning model of spontaneous abortion based on combination of serum miRNAs

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023490
Enrollment
Unknown
Registered
2019-05-31
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spontaneous abortion

Interventions

Healthy control group:None
spontaneous abortion group:none

Sponsors

Nanjing Maternity and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Spontaneous abortion group inclusion criteria: Diagnosed spontaneous abortion pregnant women according to Obstetrics and Gynecology (The ninth edition, 2018). Normal pregnancy group inclusion criteria: Pregnant women had no previous spontaneous abortion, stillbirth history. And there were no symptoms and signs of threatened abortion such as vaginal bleeding and abdominal pain during this pregnancy; and ultrasound confirmed that the embryo was developing normally. All pregnant women in two groups meet the following inclusion criteria: 1.Aged between 20 and 45 years. 2.Gestational weeks less than 28 weeks. 3.Signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who had other high-risk factors which might relate with spontaneous abortion, including: (1) Karyotype abnormalities, single gene and/or polygenetic hereditary diseases; (2) Anatomical abnormalities of genital tract: any congenital anatomical abnormalities of uterus; intrauterine adhesions; myoma of uterus; endometrial polyps; (3) Endocrine abnormalities; (4) Autoimmune disorders; (5) Hypercoagulation state; (6) Negative RH blood groups; (7) Abnormal semen results of patients husband. 2.Patients with serious diseases; 3.Patients with administration of contraceptive pills; 4.Patients could not be followed-up of a long time or had poor compliance; 5.Patients with other factors that would affect the study result.

Design outcomes

Primary

MeasureTime frame
miR-515-3p;miR-517a;miR-525-3p;miR-141;miR-200c;hCG;progesterone;Gestational age;

Countries

China

Contacts

Public ContactZhong Tianying

Nanjing Maternity and Child Health Care Hospital

zhongtianying@njmu.edu.cn+86 13851875320

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026